Stock OBIO ORCHESTRA BIOMED HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Orchestra BioMed Holdings, Inc.

Equities

OBIO

US68572M1062

Delayed Nasdaq
Other stock markets
 18:20:19 23/05/2024 BST 		5-day change 1st Jan Change
5.37 USD +1.32% Intraday chart for Orchestra BioMed Holdings, Inc. +16.23% -41.18%
05-13 Earnings Flash (OBIO) ORCHESTRA BIOMED HOLDINGS Reports Q1 Revenue $620,000 MT
05-13 Orchestra BioMed Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
GL
Earnings Flash (OBIO) ORCHESTRA BIOMED HOLDINGS Reports Q1 Revenue $620,000
MT
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GL
Orchestra BioMed Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
GL
Orchestra BioMed Holdings, Inc. Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents
CI
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
GL
Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024
AQ
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GL
Orchestra BioMed Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
GL
Orchestra BioMed Holdings, Inc. Announces Appointment of David Pacitti to Board of Directors
CI
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
GL
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
AQ
Orchestra Biomed Holdings, Inc. Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
CI
Orchestra BioMed to Participate in Upcoming Investor Conferences
GL
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
GL
Orchestra Biomed Holdings, Inc. Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy in Hypertensive Pacemaker Patients
CI
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
GL
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OBIO Stock
  4. News Orchestra BioMed Holdings, Inc.